Canadian health authorities approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis, the progressive neurodegenerative disease that robs patients of their ability to move and speak.
It is the first Canadian approval since 2018 for a new drug treating the fatal condition, which is also known as Lou Gehrig’s disease.
Election Day 2024 arrived Tuesday — with tens of millions...
Credit: Screenshot via Democracy Defenders Jim Messina, the former White...
On the eve of the U.S. election, President Trump received...
Coatue Management, a hedge fund that invested heavily in tech...
A cylinder seal and its design imprinted onto clayFranck Raux...
Jonathan Haze, who starred for Roger Corman as the flower...
